Report Highlights
Global Pneumococcal Vaccines Market: Overview
This report analyzes the current and future scenario of the global pneumococcal vaccines market. Increase in patient population, growth of the pharmaceutical industry, rise in government investments for vaccination programs, improvement in health care infrastructure, and surge in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.
The global pneumococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, distribution channel, sector, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global pneumococcal vaccines market.
Global Pneumococcal Vaccines Market: Key Segments
Based on product type, the global pneumococcal vaccines market has been segmented into Synflorix, Prevenar-13, PCV 13 (pipeline), V114 (Merck), PCV-20 (Pfizer), PCV-10 (SII), and PPSV- 23. Each of these segments is categorized into pediatric and adults. In terms of distribution channel, the global market has been classified into wholesalers (pharmacy channel), specialized companies, public authorities, and others. Based on sector, the market has been bifurcated into private and public. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Pneumococcal Vaccines Market: Regional Outlook
In terms of region, the global pneumococcal vaccines market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Belgium, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World (Middle East and Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global pneumococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Pfizer, Inc., Merck & Co., Inc., SK Chemicals, Serum Institute of India Pvt. Ltd., Chengdu Institute of Biological Products Co., Ltd., GlaxoSmithKline plc, Sanofi, and Walvax Biotechnology Co., Ltd.
The global pneumococcal vaccines market has been segmented as below:
Global Pneumococcal Vaccines Market, by Product Type
Synflorix
Pediatric
Adult
Prevenar-13
Pediatric
Adult
PCV 13 (pipeline)
Pediatric
Adult
V114 (Merck)
Pediatric
Adult
PCV-20 (Pfizer)
Pediatric
Adult
PCV-10 (SII)
Pediatric
Adult
PPSV- 23
Pediatric
Adult
Global Pneumococcal Vaccines Market, by Distribution Channel
Wholesalers (pharmacy channel)
Specialized Companies
Public Authorities
Others
Global Pneumococcal Vaccines Market, by Sector
Public
Private
Global Pneumococcal Vaccines Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Belgium
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Rest of the World
Middle East
Africa
- Table 1 : Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 2 : Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 3 : Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 4 : U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 5 : U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 6 : U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 7 : U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 8 : Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 9 : Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 10 : Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 11 : Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 12 : Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 13 : Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 14 : Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 15 : Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 16 : U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 17 : U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 18 : U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 19 : U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 20 : France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 21 : France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 22 : France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 23 : France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 24 : Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 25 : Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 26 : Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 27 : Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 28 : Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 29 : Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 30 : Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 31 : Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 32 : Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 33 : Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 34 : Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 35 : Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 36 : India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 37 : India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 38 : India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 39 : India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 40 : China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 41 : China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 42 : China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 43 : China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 44 : Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 45 : Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 46 : Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 47 : Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 48 : Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 49 : Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 50 : Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 51 : Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 52 : New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 53 : New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 54 : New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 55 : New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 56 : Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 57 : Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 58 : Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 59 : Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 60 : Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 61 : Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 62 : Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 63 : Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 64 : Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 65 : Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
- Table 66 : Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 67 : Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
- Table 68 : Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Region, 2016–2026
- Table 69 : North America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country, 2016–2026
- Table 70 : Europe Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 71 : Asia Pacific Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 72 : Latin America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Figure 1 : Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, 2016–2026
- Figure 2 : Global Pneumococcal Vaccines Market Value Share (%), by Product Type (2017)
- Figure 3 : Global Pneumococcal Vaccines Market Value Share (%), by Sector (2017)
- Figure 4 : Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel (2017)
- Figure 5 : Global Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 6 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent, 2016–2026
- Figure 7 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 10-Valent (pipeline), 2016–2026
- Figure 8 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent, 2016–2026
- Figure 9 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 13-Valent (pipeline), 2016–2026
- Figure 10 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 15-Valent (pipeline), 2016–2026
- Figure 11 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 20-Valent (pipeline), 2016–2026
- Figure 12 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 23-Valent, 2016–2026
- Figure 13 : Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 14 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Wholesalers, 2016–2026
- Figure 15 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialized Companies, 2016–2026
- Figure 16 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public Authorities, 2016–2026
- Figure 17 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
- Figure 18 : Global Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 19 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Public, 2016–2026
- Figure 20 : Global Pneumococcal Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Private, 2016–2026
- Figure 21 : U.S. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 22 : U.S. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 23 : U.S. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 24 : Canada Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 25 : Canada Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 26 : Canada Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 27 : Germany Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 28 : Germany Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 29 : Germany Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 30 : U.K. Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 31 : U.K. Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 32 : U.K. Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 33 : France Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 34 : France Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 35 : France Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 36 : Italy Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 37 : Italy Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 38 : Italy Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 39 : Spain Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 40 : Spain Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 41 : Spain Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 42 : Belgium Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 43 : Belgium Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 44 : Belgium Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 45 : India Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 46 : India Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 47 : India Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 48 : China Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 49 : China Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 50 : China Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 51 : Japan Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 52 : Japan Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 53 : Japan Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 54 : New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 55 : Australia Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 56 : Australia Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 57 : New Zealand Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 58 : New Zealand Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 59 : New Zealand Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 60 : Brazil Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 61 : Brazil Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 62 : Brazil Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 63 : Mexico Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 64 : Mexico Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 65 : Mexico Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 66 : Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Product Type, 2018 and 2026
- Figure 67 : Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2018 and 2026
- Figure 68 : Rest of the World (RoW) Pneumococcal Vaccines Market Value Share (%), by Sector, 2018 and 2026
- Figure 69 : Global Pneumococcal Vaccines Market Share (%) and Market Share Range (%), by Company, 2017
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Similar Reports from Transparency
Pneumococcal Vaccines Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026
Global Pneumococcal Vaccines Market- Overview
The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media. It is also one of the leading infectious diseases. However, it can be prevented with the help of vaccination. With an increase in pneumococcal ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More